報告摘要

The global Remdesivir market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. The North America market for Remdesivir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032. The Europe market for Remdesivir is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. The Asia Pacific market for Remdesivir is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global manufacturers of Remdesivir include Kelun Pharma, Hunan Warrant Pharmaceutical, Hainan Haiyao, Bright Gene and Gilead Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue. Report Scope This report quantifies the global Remdesivir market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032. It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems. Key Companies & Market Share Insights This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking. Remdesivir Market by Company Kelun Pharma Hunan Warrant Pharmaceutical Hainan Haiyao Bright Gene Gilead Sciences Remdesivir Segment by Type 10 mM*1 mL in DMSO 100mg 10mg 50mg 5mg Remdesivir Segment by Application Drug Store Hospital Clinics Others Remdesivir Segment by Region North America United States Canada Europe Germany France U.K. Italy Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. Reasons to Buy This Report 1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remdesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. 2. This report will help stakeholders to understand the global industry status and trends of Remdesivir and provides them with information on key market drivers, restraints, challenges, and opportunities. 3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. 4. This report stays updated with novel technology integration, features, and the latest developments in the market 5. This report helps stakeholders to gain insights into which regions to target globally 6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remdesivir. 7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Chapter Outline Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Detailed analysis of Remdesivir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc. Chapter 5: Production/output, value of Remdesivir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years. Chapter 6: Consumption of Remdesivir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world. Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 11: The main points and conclusions of the report.

目錄 Table of Contents

1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Global Market Growth Prospects 2.2.1 Global Remdesivir Market Size (2021-2032) 2.2.2 Global Remdesivir Sales (2021-2032) 2.2.3 Global Remdesivir Market Average Price (2021-2032) 2.3 Remdesivir by Type 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) 2.3.2 10 mM*1 mL in DMSO 2.3.3 100mg 2.3.4 10mg 2.3.5 50mg 2.3.6 5mg 2.4 Remdesivir by Application 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) 2.4.2 Drug Store 2.4.3 Hospital 2.4.4 Clinics 2.4.5 Others 3 Market Competitive Landscape by Manufacturers 3.1 Global Remdesivir Market Competitive Situation by Manufacturers (2021 Versus 2025) 3.2 Global Remdesivir Sales (K Units) of Manufacturers (2021-2026) 3.3 Global Remdesivir Revenue of Manufacturers (2021-2026) 3.4 Global Remdesivir Average Price by Manufacturers (2021-2026) 3.5 Global Remdesivir Industry Ranking, 2024 VS 2025 VS 2026 3.6 Global Manufacturers of Remdesivir, Manufacturing Sites & Headquarters 3.7 Global Manufacturers of Remdesivir, Product Type & Application 3.8 Global Manufacturers of Remdesivir, Established Date 3.9 Global Remdesivir Market CR5 and HHI 3.10 Global Manufacturers Mergers & Acquisition 4 Manufacturers Profiled 4.1 Kelun Pharma 4.1.1 Kelun Pharma Company Information 4.1.2 Kelun Pharma Business Overview 4.1.3 Kelun Pharma Remdesivir Sales, Revenue and Gross Margin (2021-2026) 4.1.4 Kelun Pharma Remdesivir Product Portfolio 4.1.5 Kelun Pharma Recent Developments 4.2 Hunan Warrant Pharmaceutical 4.2.1 Hunan Warrant Pharmaceutical Company Information 4.2.2 Hunan Warrant Pharmaceutical Business Overview 4.2.3 Hunan Warrant Pharmaceutical Remdesivir Sales, Revenue and Gross Margin (2021-2026) 4.2.4 Hunan Warrant Pharmaceutical Remdesivir Product Portfolio 4.2.5 Hunan Warrant Pharmaceutical Recent Developments 4.3 Hainan Haiyao 4.3.1 Hainan Haiyao Company Information 4.3.2 Hainan Haiyao Business Overview 4.3.3 Hainan Haiyao Remdesivir Sales, Revenue and Gross Margin (2021-2026) 4.3.4 Hainan Haiyao Remdesivir Product Portfolio 4.3.5 Hainan Haiyao Recent Developments 4.4 Bright Gene 4.4.1 Bright Gene Company Information 4.4.2 Bright Gene Business Overview 4.4.3 Bright Gene Remdesivir Sales, Revenue and Gross Margin (2021-2026) 4.4.4 Bright Gene Remdesivir Product Portfolio 4.4.5 Bright Gene Recent Developments 4.5 Gilead Sciences 4.5.1 Gilead Sciences Company Information 4.5.2 Gilead Sciences Business Overview 4.5.3 Gilead Sciences Remdesivir Sales, Revenue and Gross Margin (2021-2026) 4.5.4 Gilead Sciences Remdesivir Product Portfolio 4.5.5 Gilead Sciences Recent Developments 5 Global Remdesivir Market Scenario by Region 5.1 Global Remdesivir Market Size by Region: 2021 VS 2025 VS 2032 5.2 Global Remdesivir Sales by Region: 2021-2032 5.2.1 Global Remdesivir Sales by Region: 2021-2026 5.2.2 Global Remdesivir Sales by Region: 2027-2032 5.3 Global Remdesivir Revenue by Region: 2021-2032 5.3.1 Global Remdesivir Revenue by Region: 2021-2026 5.3.2 Global Remdesivir Revenue by Region: 2027-2032 5.4 North America Remdesivir Market Facts & Figures by Country 5.4.1 North America Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 5.4.2 North America Remdesivir Sales by Country (2021-2032) 5.4.3 North America Remdesivir Revenue by Country (2021-2032) 5.4.4 United States 5.4.5 Canada 5.5 Europe Remdesivir Market Facts & Figures by Country 5.5.1 Europe Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 5.5.2 Europe Remdesivir Sales by Country (2021-2032) 5.5.3 Europe Remdesivir Revenue by Country (2021-2032) 5.5.4 Germany 5.5.5 France 5.5.6 U.K. 5.5.7 Italy 5.5.8 Netherlands 5.5.9 Nordic Countries 5.6 Asia Pacific Remdesivir Market Facts & Figures by Country 5.6.1 Asia Pacific Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 5.6.2 Asia Pacific Remdesivir Sales by Country (2021-2032) 5.6.3 Asia Pacific Remdesivir Revenue by Country (2021-2032) 5.6.4 China 5.6.5 Japan 5.6.6 South Korea 5.6.7 India 5.6.8 Australia 5.6.9 China Taiwan 5.6.10 Southeast Asia 5.7 South America Remdesivir Market Facts & Figures by Country 5.7.1 South America Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 5.7.2 South America Remdesivir Sales by Country (2021-2032) 5.7.3 South America Remdesivir Revenue by Country (2021-2032) 5.7.4 Mexico 5.7.5 Brazil 5.7.6 Argentina 5.7.7 Colombia 5.8 Middle East and Africa Remdesivir Market Facts & Figures by Country 5.8.1 Middle East and Africa Remdesivir Market Size by Country: 2021 VS 2025 VS 2032 5.8.2 Middle East and Africa Remdesivir Sales by Country (2021-2032) 5.8.3 Middle East and Africa Remdesivir Revenue by Country (2021-2032) 5.8.4 Turkey 5.8.5 Saudi Arabia 5.8.6 UAE 6 Segment by Type 6.1 Global Remdesivir Sales by Type (2021-2032) 6.1.1 Global Remdesivir Sales by Type (2021-2032) & (K Units) 6.1.2 Global Remdesivir Sales Market Share by Type (2021-2032) 6.2 Global Remdesivir Revenue by Type (2021-2032) 6.2.1 Global Remdesivir Sales by Type (2021-2032) & (US$ Million) 6.2.2 Global Remdesivir Revenue Market Share by Type (2021-2032) 6.3 Global Remdesivir Price by Type (2021-2032) 7 Segment by Application 7.1 Global Remdesivir Sales by Application (2021-2032) 7.1.1 Global Remdesivir Sales by Application (2021-2032) & (K Units) 7.1.2 Global Remdesivir Sales Market Share by Application (2021-2032) 7.2 Global Remdesivir Revenue by Application (2021-2032) 7.2.1 Global Remdesivir Sales by Application (2021-2032) & (US$ Million) 7.2.2 Global Remdesivir Revenue Market Share by Application (2021-2032) 7.3 Global Remdesivir Price by Application (2021-2032) 8 Value Chain and Sales Channels Analysis of the Market 8.1 Remdesivir Value Chain Analysis 8.1.1 Remdesivir Key Raw Materials 8.1.2 Raw Materials Key Suppliers 8.1.3 Remdesivir Production Mode & Process 8.2 Remdesivir Sales Channels Analysis 8.2.1 Direct Comparison with Distribution Share 8.2.2 Remdesivir Distributors 8.2.3 Remdesivir Customers 9 Global Remdesivir Analyzing Market Dynamics 9.1 Remdesivir Industry Trends 9.2 Remdesivir Industry Drivers 9.3 Remdesivir Industry Opportunities and Challenges 9.4 Remdesivir Industry Restraints 10 Report Conclusion 11 Disclaimer

圖表清單 List of Tables & Figures

List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Remdesivir Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Remdesivir Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Remdesivir Sales Market Share by Manufacturers (2021-2026) Table 8. Global Remdesivir Revenue of Manufacturers (2021-2026) Table 9. Global Remdesivir Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Remdesivir Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Remdesivir Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Remdesivir, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Remdesivir, Product Type & Application Table 14. Global Remdesivir Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Remdesivir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Kelun Pharma Company Information Table 19. Kelun Pharma Business Overview Table 20. Kelun Pharma Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Kelun Pharma Remdesivir Product Portfolio Table 22. Kelun Pharma Recent Developments Table 23. Hunan Warrant Pharmaceutical Company Information Table 24. Hunan Warrant Pharmaceutical Business Overview Table 25. Hunan Warrant Pharmaceutical Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Hunan Warrant Pharmaceutical Remdesivir Product Portfolio Table 27. Hunan Warrant Pharmaceutical Recent Developments Table 28. Hainan Haiyao Company Information Table 29. Hainan Haiyao Business Overview Table 30. Hainan Haiyao Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Hainan Haiyao Remdesivir Product Portfolio Table 32. Hainan Haiyao Recent Developments Table 33. Bright Gene Company Information Table 34. Bright Gene Business Overview Table 35. Bright Gene Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Bright Gene Remdesivir Product Portfolio Table 37. Bright Gene Recent Developments Table 38. Gilead Sciences Company Information Table 39. Gilead Sciences Business Overview Table 40. Gilead Sciences Remdesivir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Gilead Sciences Remdesivir Product Portfolio Table 42. Gilead Sciences Recent Developments Table 43. Global Remdesivir Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Remdesivir Sales by Region (2021-2026) & (K Units) Table 45. Global Remdesivir Sales Market Share by Region (2021-2026) Table 46. Global Remdesivir Sales by Region (2027-2032) & (K Units) Table 47. Global Remdesivir Sales Market Share by Region (2027-2032) Table 48. Global Remdesivir Revenue by Region (2021-2026) & (US$ Million) Table 49. Global Remdesivir Revenue Market Share by Region (2021-2026) Table 50. Global Remdesivir Revenue by Region (2027-2032) & (US$ Million) Table 51. Global Remdesivir Revenue Market Share by Region (2027-2032) Table 52. North America Remdesivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. North America Remdesivir Sales by Country (2021-2026) & (K Units) Table 54. North America Remdesivir Sales by Country (2027-2032) & (K Units) Table 55. North America Remdesivir Revenue by Country (2021-2026) & (US$ Million) Table 56. North America Remdesivir Revenue by Country (2027-2032) & (US$ Million) Table 57. Europe Remdesivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Europe Remdesivir Sales by Country (2021-2026) & (K Units) Table 59. Europe Remdesivir Sales by Country (2027-2032) & (K Units) Table 60. Europe Remdesivir Revenue by Country (2021-2026) & (US$ Million) Table 61. Europe Remdesivir Revenue by Country (2027-2032) & (US$ Million) Table 62. Asia Pacific Remdesivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Asia Pacific Remdesivir Sales by Country (2021-2026) & (K Units) Table 64. Asia Pacific Remdesivir Sales by Country (2027-2032) & (K Units) Table 65. Asia Pacific Remdesivir Revenue by Country (2021-2026) & (US$ Million) Table 66. Asia Pacific Remdesivir Revenue by Country (2027-2032) & (US$ Million) Table 67. South America Remdesivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. South America Remdesivir Sales by Country (2021-2026) & (K Units) Table 69. South America Remdesivir Sales by Country (2027-2032) & (K Units) Table 70. South America Remdesivir Revenue by Country (2021-2026) & (US$ Million) Table 71. South America Remdesivir Revenue by Country (2027-2032) & (US$ Million) Table 72. Middle East and Africa Remdesivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Middle East and Africa Remdesivir Sales by Country (2021-2026) & (K Units) Table 74. Middle East and Africa Remdesivir Sales by Country (2027-2032) & (K Units) Table 75. Middle East and Africa Remdesivir Revenue by Country (2021-2026) & (US$ Million) Table 76. Middle East and Africa Remdesivir Revenue by Country (2027-2032) & (US$ Million) Table 77. Global Remdesivir Sales by Type (2021-2026) & (K Units) Table 78. Global Remdesivir Sales by Type (2027-2032) & (K Units) Table 79. Global Remdesivir Sales Market Share by Type (2021-2026) Table 80. Global Remdesivir Sales Market Share by Type (2027-2032) Table 81. Global Remdesivir Revenue by Type (2021-2026) & (US$ Million) Table 82. Global Remdesivir Revenue by Type (2027-2032) & (US$ Million) Table 83. Global Remdesivir Revenue Market Share by Type (2021-2026) Table 84. Global Remdesivir Revenue Market Share by Type (2027-2032) Table 85. Global Remdesivir Price by Type (2021-2026) & (US$/Unit) Table 86. Global Remdesivir Price by Type (2027-2032) & (US$/Unit) Table 87. Global Remdesivir Sales by Application (2021-2026) & (K Units) Table 88. Global Remdesivir Sales by Application (2027-2032) & (K Units) Table 89. Global Remdesivir Sales Market Share by Application (2021-2026) Table 90. Global Remdesivir Sales Market Share by Application (2027-2032) Table 91. Global Remdesivir Revenue by Application (2021-2026) & (US$ Million) Table 92. Global Remdesivir Revenue by Application (2027-2032) & (US$ Million) Table 93. Global Remdesivir Revenue Market Share by Application (2021-2026) Table 94. Global Remdesivir Revenue Market Share by Application (2027-2032) Table 95. Global Remdesivir Price by Application (2021-2026) & (US$/Unit) Table 96. Global Remdesivir Price by Application (2027-2032) & (US$/Unit) Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Remdesivir Distributors List Table 100. Remdesivir Customers List Table 101. Remdesivir Industry Trends Table 102. Remdesivir Industry Drivers Table 103. Remdesivir Industry Restraints Table 104. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Remdesivir Product Image Figure 5. Global Remdesivir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Remdesivir Market Size (2021-2032) & (US$ Million) Figure 7. Global Remdesivir Sales (2021-2032) & (K Units) Figure 8. Global Remdesivir Average Price (US$/Unit) & (2021-2032) Figure 9. 10 mM*1 mL in DMSO Product Image Figure 10. 100mg Product Image Figure 11. 10mg Product Image Figure 12. 50mg Product Image Figure 13. 5mg Product Image Figure 14. Drug Store Product Image Figure 15. Hospital Product Image Figure 16. Clinics Product Image Figure 17. Others Product Image Figure 18. Global Remdesivir Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Remdesivir, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Remdesivir Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Remdesivir Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Remdesivir Sales by Region in 2025 Figure 24. Global Remdesivir Revenue by Region in 2025 Figure 25. North America Remdesivir Market Size by Country in 2025 Figure 26. North America Remdesivir Sales Market Share by Country (2021-2032) Figure 27. North America Remdesivir Revenue Market Share by Country (2021-2032) Figure 28. United States Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Remdesivir Market Size by Country in 2025 Figure 31. Europe Remdesivir Sales Market Share by Country (2021-2032) Figure 32. Europe Remdesivir Revenue Market Share by Country (2021-2032) Figure 33. Germany Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Nordic Countries Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Remdesivir Market Size by Country in 2025 Figure 40. Asia Pacific Remdesivir Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Remdesivir Revenue Market Share by Country (2021-2032) Figure 42. China Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Remdesivir Market Size by Country in 2025 Figure 51. South America Remdesivir Sales Market Share by Country (2021-2032) Figure 52. South America Remdesivir Revenue Market Share by Country (2021-2032) Figure 53. Mexico Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Colombia Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Remdesivir Market Size by Country in 2025 Figure 58. Middle East and Africa Remdesivir Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Remdesivir Revenue Market Share by Country (2021-2032) Figure 60. Turkey Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. UAE Remdesivir Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Global Remdesivir Sales Market Share by Type (2021-2032) Figure 64. Global Remdesivir Revenue Market Share by Type (2021-2032) Figure 65. Global Remdesivir Price (US$/Unit) by Type (2021-2032) Figure 66. Global Remdesivir Sales Market Share by Application (2021-2032) Figure 67. Global Remdesivir Revenue Market Share by Application (2021-2032) Figure 68. Global Remdesivir Price (US$/Unit) by Application (2021-2032) Figure 69. Remdesivir Value Chain Figure 70. Remdesivir Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Remdesivir Industry Opportunities and Challenges

Single User	$2,950 USD
Multi User	$4,430 USD
Enterprise	$5,900 USD

Remdesivir Industry Research Report 2026

授權報價

報告摘要

提及公司